From: Novel 89Zr cell labeling approach for PET-based cell trafficking studies
Isotope-compound/ T 1/2 | Cells labeled | Labeling and imaging characteristics | Reference |
---|---|---|---|
111In-oxine/67.4 h | Leukocytes | Approximately 80% cell labeling yield in 30 min | |
Lymphocytes | Significant efflux rate reported in lymphocytes (approximately 70% effluxed in 24 h) and HPCs (approximately 75% effluxed in 96 h) | ||
HPCs | Suboptimal image quality and sensitivity | ||
64Cu-PTSM/12.7 h | C6 glioma cells | 70% to 85% cell labeling yield in 5 h | [7] |
Significant efflux rate from cells (approximately 80% effluxed in 24 h) | |||
64Cu-TETA- or 89Zr-DFO-antiCD45/12.7 h (64Cu), 78.4 h (89Zr) | hPBSCs | Binds to only CD45 membrane protein expressing cells | [8] |
Approach was suboptimal possibly due to insufficient CD45 molecules on the plasma membrane of stem cells | |||
89Zr-oxine/78.4 h | Myeloma cells and natural killer cells | Approximately 32% cell labeling yield in 30 min | |
Significant efflux rate reported for myeloma cells (29% effluxed in 24 h) and natural killer cells (70% to 80% effluxed in 7 days) | |||
Loss of cell viability possibly due to oxine exposure | |||
89Zr-protamine sulfate/78.4 h | Dendritic cells and T lymphocytes | Approximately 34% cell labeling yield (dendritic cells) in 30 min | [11] |
Approximately 12% cell labeling yield (T lymphocytes) in 30 min | |||
Weakly binds to non-specific intracellular biomolecules | |||
Efflux rate not reported |